News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
124 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24953)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Medtech Titan Boston Scientific Throws $90M Into Millipede With an Option to Acquire
Boston Sci has the option to acquire the remaining shares of the company at any time prior to the completion of a first in human clinical study that meets certain parameters.
January 24, 2018
·
5 min read
Business
Imprimis Pharma is Issued DEA Manufacturer Certificate for its 503B Outsourcing Facility
This new registration will further allow Imprimis to leverage its national compounding platform and its relationships with nearly 2,000 ophthalmology and optometric customers.
January 24, 2018
·
3 min read
FDA
Perrigo Announces Final FDA Approval and Launch of an AB Rated Generic Version of Epiduo Gel
Perrigo today announced it has received final approval from the FDA and has launched an AB rated generic version of Epiduo Gel, 0.1%/2.5%.
January 24, 2018
·
4 min read
FDA
Perrigo Announces Final FDA Approval of a Generic Version of Estrace Cream
This product will be marketed by Perrigo’s partner, Impax, and is currently expected to launch in the second quarter of this year.
January 24, 2018
·
4 min read
Business
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2017
Enanta today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2017, after the U.S. markets close on February 7, 2018.
January 24, 2018
·
2 min read
Business
Dr Monica Saini Joins Volpara Solutions as Consultant Diagnostic Radiologist
Dr Saini brings a deep understanding of breast imaging and will help Volpara Solutions accelerate the development of its clinical applications suite of quantitative breast imaging tools.
January 24, 2018
·
2 min read
Biotech Bay
Hospitals Adopt Omnicell’s IV Compounding Automation to Support Patient Safety and Quality Initiatives
Omnicell today announced that a number of hospitals across North America have adopted the company’s IV compounding technology to help enhance safety, improve therapy, reduce cost, and facilitate compliance in the IV room.
January 24, 2018
·
3 min read
Business
ImmunoGen Appoints Stuart A. Arbuckle to Board of Directors
Mr. Arbuckle is replacing Howard Pien, who is stepping down from ImmunoGen’s Board after eight years of service.
January 24, 2018
·
4 min read
Genetown
Synlogic Announces Pricing of Public Offering of Common Stock
Synlogic today announced the pricing of its underwritten public offering of 5,130,000 shares of its common stock at a public offering price of $9.75 per share.
January 24, 2018
·
5 min read
Pharm Country
Simulations Plus Subsidiary Cognigen Releases KIWI Version 2
Cognigen today announced that it has released Version 2 of its KIWI Pharmacometric Communication and Collaboration Platform.
January 24, 2018
·
4 min read
Previous
3 of 13
Next